June 09, 2005

Novo Nordisk A/S et al v. Caraco Pharmaceutical Laboratories, Limited

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 25, 2011

    Caraco Denied Quick Win On Prandin IP Misuse Claim

    A federal judge in Michigan on Thursday refused to analyze Caraco Pharmaceutical Laboratories Ltd.'s contention that Novo Nordisk A/S misused its patent for the diabetes drug Prandin, finding the matter inappropriate to consider in light of pending appeals.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login